Ironwood Pharmaceuticals | IRWD - Operating Profit


Ironwood Pharmaceuticals reported $33.22M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Agios Pharmaceuticals USD -116.87M 10.19M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
Alnylam Pharmaceuticals USD -29.96M 13.76M Sep/2025
Amarin USD -1.7M 8.47M Sep/2025
Ardelyx USD 4.67M 19.07M Sep/2025
Astellas Pharma JPY 134.54B 30.13B Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Exact Sciences USD -25M 22.85M Sep/2025
Halozyme Therapeutics USD 217.92M 15.48M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
MacroGenics USD 18.64M 55.4M Sep/2025
Moderna USD -260M 647M Sep/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Pacira USD 13.15M 2.92M Sep/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Takeda JPY 168.82B 479.89B Dec/2025
Ultragenyx Pharmaceutical USD -170.89M 22.68M Sep/2025